Literature DB >> 2255517

Prolonged recoverability of desiccated adenovirus type 19 from various surfaces.

R C Nauheim1, E G Romanowski, T Araullo-Cruz, R P Kowalski, P W Turgeon, S S Stopak, Y J Gordon.   

Abstract

Epidemic keratoconjunctivitis is a highly contagious disease whose transmission has been linked to the ophthalmologist's office. The authors studied the ability of adenovirus 19 (ADV 19) to survive on surfaces commonly found in the office setting. An initial in vitro laboratory experiment demonstrated that ADV 19 in a desiccated state could be recovered up to 8 days from paper, and up to 10 days from cloth, metal, and plastic. The amount of recovered ADV 19 was significantly greater (analysis of variance, P less than 0.0001) from nonporous surfaces (plastic, metal) compared with porous surfaces (cloth, paper). A second experiment demonstrated that 35 days was the maximum length of time that desiccated ADV 19 could be recovered from a nonporous surface (plastic). The authors conclude that despite drying, ADV 19 is a hearty virus that remains potentially infectious for a long time on various surfaces that may be found in an ophthalmologist's office.

Entities:  

Mesh:

Year:  1990        PMID: 2255517     DOI: 10.1016/s0161-6420(90)32389-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan.

Authors:  S Takeuchi; N Itoh; E Uchio; K Tanaka; N Kitamura; H Kanai; K Isobe; K Aoki; S Ohno
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

2.  Identification of the hexon region of an adenovirus involved in a new outbreak of keratoconjunctivitis.

Authors:  Y Imai; S Kameya; M Ohkoshi; K Yamaki; S Sakuragi
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

3.  First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults.

Authors:  Hamid Jalal; David F Bibby; Julian W Tang; Julie Bennett; Chara Kyriakou; Karl Peggs; David Cubitt; Nicola S Brink; Kate N Ward; Richard S Tedder
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

4.  Quantitative detection and rapid identification of human adenoviruses.

Authors:  Rika Miura-Ochiai; Yasushi Shimada; Tsunetada Konno; Shudo Yamazaki; Koki Aoki; Shigeaki Ohno; Eitaro Suzuki; Hiroaki Ishiko
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

5.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

6.  Ultrastructure of adenovirus keratitis.

Authors:  Santanu Mukherjee; Xiaohong Zhou; Jaya Rajaiya; James Chodosh
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

Review 7.  Common ocular infections. A prescriber's guide.

Authors:  S P Donahue; J M Khoury; R P Kowalski
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

8.  Human adenovirus: Viral pathogen with increasing importance.

Authors:  B Ghebremedhin
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

9.  Novel human adenovirus causing nosocomial epidemic keratoconjunctivitis.

Authors:  Hiroaki Ishiko; Yasushi Shimada; Tsunetada Konno; Akio Hayashi; Takeshi Ohguchi; Yoshitsugu Tagawa; Koki Aoki; Shigeaki Ohno; Shudo Yamazaki
Journal:  J Clin Microbiol       Date:  2008-04-02       Impact factor: 5.948

10.  Molecular diagnosis of human adenoviruses d and e by a phylogeny-based classification method using a partial hexon sequence.

Authors:  Yasushi Shimada; Toshihide Ariga; Yoshitsugu Tagawa; Koki Aoki; Shigeaki Ohno; Hiroaki Ishiko
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.